Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05751733
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2023-02-08
Brief Title:
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Sponsor:
Xiangya Hospital of Central South University
Organization:
Xiangya Hospital of Central South University
Organization Data
Organization:
Xiangya Hospital of Central South University
Class:
OTHER
Study ID:
XYGIST202202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xiangya Hospital of Central South University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Suzhou Suncadia Biopharmaceuticals Co Ltd | INDUSTRY |